U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 208685

EMFLAZA (DEFLAZACORT)
22.75MG/ML
Marketing Status: Prescription
Active Ingredient: DEFLAZACORT
Proprietary Name: EMFLAZA
Dosage Form; Route of Administration: SUSPENSION; ORAL
Strength: 22.75MG/ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N208685
Product Number: 001
Approval Date: Feb 9, 2017
Applicant Holder Full Name: PTC THERAPEUTICS INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top